Genomic alterations are associated with response to aromatase inhibitor therapy for ER-positive postmenopausal ductal carcinoma in situ: (CALGB 40903, Alliance) by Jeffrey R. Marks, Dadong Zhang, Timothy Hardman, Yunn-yi Chen, Allison Hall, Lunden Simpson, Tina Hieken, Isabelle Bedrosian, Elissa Price, Jeff Sheng, Yanwan Dai, Marissa Lee, Alexander B. Sibley, Kouros Owzar, E. Shelley Hwang

Get full text